Aromatase



5 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information
A10075 SALE

Anastrozole

Aromatase inhibitor

Anastrozole binds reversibly to the aromatase enzyme through competitive inhibition, inhibits the conversion of androgens to estrogens in peripheral tissues (outside the CNS), and a few CNS sites in various regions within the brain. The severity of breast cancer is increased by estrogen, as sex hormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen.

A10378 SALE

Exemestane

Aromatase inhibitor
Exemestane is an oral steroidal aromatase inhibitor that is used in ER-positive breast cancer in addition to surgery and/or radiation in post-menopausal women.
A11088

Fadrozole

-
Fadrozole is a nonsteroidal aromatase inhibitor exhibiting a very potent and selective inhibitory effect of the aromatase enzyme system in vivo and estrogen biosynthesis in vivo.
A10523 SALE

Letrozole

Aromatase inhibitor
Letrozole is an Aromatase inhibitor. CGS 20267 is a new non-steroidal compound which potently inhibits aromatase in vitro (IC50 of 11.5 nM) and in vivo (ED50 of 1–3 μg/kg p.o.)
A10563 SALE

Megestrol Acetate

-
Megestrol Acetate is a progesterone derivative with antineoplastic properties

5 Item(s)

per page

Set Descending Direction